Syprine (Trientine Hydrochloride) 250 mg

Syprine (Trientine Hydrochloride) 250 mg

Syprine

Trientine Hydrochloride

250 mg

Bausch Health Companies Inc.

Medical Use

Aduhelm is an antibody targeting amyloid beta, used in treating Alzheimer’s disease (AD). It’s recommended to begin treatment in patients experiencing mild cognitive impairment or in the early stages of dementia. For inquiries, please Call/WhatsApp: +91 9310090915.

Dosage Instructions: After an initial titration period, the advised dosage of Aduhelm is 10 mg/kg. This is administered via an intravenous (IV) infusion over about 60 minutes, every four weeks, with a minimum interval of 21 days between doses.

If a dose is missed, resume the infusion at the same dosage as soon as possible. Ensure that infusions are scheduled every four weeks, maintaining at least a 21-day gap between them.